This significantly extends our previous assessment of STn expression in some of the long term established ovarian cancer cell lines and xenograft model with the mouse anti-STn-ADC and the more recent investigations characterization of the humanized anti-STn-ADC [4–6]. Here, EEF1A2 is linked to ovarian carcinoma.